Serum neutrophil gelatinase-associated lipocalin levels in patients with non-dipper hypertension

Clinical and Investigative Medicine

Volumn 38, Issue 2, 2015, Pages E53-E62

  Aksan, Gökhan ^a   Inci, Sinan ^b   Nar, Gökay ^b   Siğirci, Serhat ^a   Gedikli, Ömer ^c   Soylu, Korhan ^d   Nar, Rukiye ^b   Yüksel, Serkan ^d   Şahin, Mahmut ^d  

^a SISLI HAMIDIYE ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Aksaray State Hospital   (Turkey)

^c Artvin State Hospital   (Turkey)

^d ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; HYPERTENSIVE PATIENT; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; CIRCADIAN RHYTHM; HYPERTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE-PHASE PROTEINS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; LIPOCALINS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS;

EID: 84929377025     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. J Am Med Assoc 1996; 275(20):1571-76.
2. Ermis N, Yagmur J, Acikgoz N, Cansel M, Cuglan B, Pekdemir H, Ozdemir R. Serum gamma-glutamyl transferase (GGT) levels and inflammatory activity in patients with non-dipper hypertension. Clin Exp Hypertens. 2012;34(5):311-5
3. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation 1990;81:700-2.
4. Birkenhager AM, Van den Meiracker AH. Causes and consequences of a non-dipping blood pressure profile. Neth J Med 2007;65:127-31.
5. Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, Guerrini E.'Non-dipper' hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995;43:382-7.
6. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Satoh H, Hisamichi S. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens 1997;10:1201-7.
7. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996;27:130-5.
8. Seo HS, Kang TS, Park S, Choi EY, Ko YG, Choi D, Ha J, Rim SJ, Chung N. Non-dippers are associated with advers cardiac remodeling and dysfunction. Int J Cardiol. 2006;112:171-7.
9. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 1994;83(3):799-807
10. Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta. 2000;1482:298-307.
11. De Geus HR, Bakker J, Lesaffre EM, Ie Noble JL. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 2011;183:907-14
12. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009;4:337-44
13. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, Thoren P, Hansson GK. Expression of neutrophil gelatinase associated lipocalin in atherosclerosis and myocardial infarction Arterioscler Thromb Vasc Biol 2006;26(1):136-42
14. Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinaseassociated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001;276:37258-65.
15. Choi KM, Lee JS, Kim EJ, Baik SH, Seo HS, Choi DS, Oh DJ, Park CG. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol 2008;158:203-7.
16. Zografos T, Haliassos A, Korovesis S, Giazitzoglou E, Voridis E, Katritsis D. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol 2009;104:917-20
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72
18. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension 2007; 25(6):1105-87.
19. Izzedine H, Launay-Vacher V, Deray G. Abnormal blood pressure circadian rhythm: A target organ damage? Int J Cardiol. 2006;107:343-9
20. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000;36:894-900.
21. Rahman M, Griffin V, Heyka R, Hoit B. Diurnal variation of blood pressure; reproducibility and association with left ventricular hypertrophy in hemodialysis patients. Blood Press Monit 2005;10:25-32.
22. Hojo Y, Noma S, Ohki T, Nakajima H, Satoh Y. Autonomic nervous system activity in essential hypertension: a comparison between dippers and non-dippers. J Hum Hypertens 1997;11:665-71
23. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, Buemi M. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a marker of kidney damage. Am J Kidney 2008;52:595-605
24. Aksan G, Soylu K, Aksoy O, Ozdemir M, Yanik A, Yuksel S, Gedikli Ö, Gulel O, Sahin M. The relationship between gelatinase-associated lipocalin levels and the slow coronary flow phenomenon. Coron Artery Dis. 2014;25(6):505-9
25. Soylu K, Aksan G, Nar G, Ozdemir M, Gulel O, Inci S, Aksakal A, Soylu AI, Yilmaz O. Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome. Anadolu Kardiyol Derg. 2014 July16. doi:10.5152/akd.2014.5513. [Epub ahead of print]
26. Giles TD. Assessment of global risk: a foundation for a new, better definition of hypertension. J Clin Hypertens, 2006;8(s8):5-14
27. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF alpha) and essential hypertension. J Hum Hypertens, 2005;19:149-54
28. Erden M, Kocaman SA, Poyraz F, Topal S, Sahinarslan A, Boyaci B, Cengel A, Yalçin MR. Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals.Archives of the Turkish Society of Cardiology. 2011;39:531-9 "
29. Elneihoum AM, Falke P, Hedblad B, Lindgarde F, Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors, Atherosclerosis. 1997;131(1):79-84
30. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, Lancet. 2005;365(9466):1231-8
31. Reghunathan R, Jayapal M, Hsu LY, Chng HH, Tai D, Leung BP, Melendez AJ. Expression profile of immune response genes in patients with severe acute respiratory syndrome, BMC Immunology. 2005;6:2
32. Kafkas N, Demponeras C, Zoubouloglou F, Spanou L, Babalis D, Makris K. Serum levels of geletinase associated lipocalin as indicator of the inflammatory status in coronary artery disease. Int. J. Inflam. 2012;2012:189797
33. Lindberg S, Jensen JS, Mogelvang R, Pedersen SH, Galatius S, Flyvbjerg A, Magnusson NE. Plasma neutrophil gelatinaseassociated lipocalin in the general population: association with inflammation and prognosis. Arterioscler Thromb Vasc Biol. 2014;34(9):2135-42
34. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endotheliumdependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-74.
35. Higashi Y, Nakagawa K, Kimura M, Noma K, Hara K, Sasaki S, Goto C, Oshima T, Chayama K, Yoshizumi M. Circadian varia-tion of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and nondippers. J Am Coll Cardiol 2002;40(11):2039-43
36. Kim S, Kim NH, Kim YK, Yoo JH, Shin SN, Ko JS, Kim YK, Rhee SJ, Yun KH, Lee EM, Yoo NJ, Oh SK, Jeong JW. The number of endothelial progenitor cells is decreased in patients with non-dipper hypertension. Korean Circ J. 2012;42(5):329-34
37. Stefanadis C, Wooley CF, Bush CA, Kolibash AL, Boudoulas J. Aortic distensibility abnormalities in coronary artery disease. Am J Cardiol. 1987;59:1300-4.
38. Erdogan D, Gullu H, Caliskan M, Yildirim I, Baycan S, Ciftci O, Muderrisoglu H. The influence of circadian blood pressure changes on aortic distensibility and left ventricular diastolic function in hypertensive individuals. Int J Cardiovasc Imaging 2006;22:157-165
39. Kuzeytemiz M, Karaagac K, Vatansever F, Ozluk OA, Yilmaz M, Arslan B, Peker T. The effect of non-dipper and dipper blood pressure patterns on aortic elasticity in patients with metabolic syndrome. Clin Exp Hypertens 2013;35:632-6
40. Soylu K, Nar G, Aksan G, Gedikli O, Inci S, Yuksel S, Nar R, Soylu AI, Gülel O, Sahin M. Serum neutrophil gelatinaseassociated lipocalin levels and aortic stiffness in noncritical coronary artery disease. Cardiorenal Med. 2014;4:147-54
41. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45(2):240-5
42. Ortiz LG, Marcos MG, Moreiras JM, Elena LG, Rodriguez JR, Sanchez YC, Grandes G, Salgado CM. Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LODRISK study). Blood Pressure Monitoring 2009;14:145-51
43. Park CG, Choi KM. Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension. Clin Exp Hypertens. 2014;36(7):478-83.
44. Giaginis C, Zira A, Katsargyris A, Klonaris C, Theocharis S. Clinical implication of plasma neutrophil gelatinaseassociated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis. Clin Chem Lab Med 2010;48:1035-41.